US Patent Issued to Regeneron Pharmaceuticals on Oct. 7 for "Methods for predicting and modulating glycation of a protein" (New York, Connecticut Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,436,152, issued on Oct. 7, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Methods for predicting and modulating glycation of a protein" was invented by Haibo Qiu (Millwood, N.Y.), Xiaobin Xu (Old Greenwich, Conn.), Douglas Kamen (Poughquag, N.Y.), Teng-Chieh Yang (Stratford, Conn.) and Kenneth Graham (Pleasant Valley, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments provide for methods of predicting glycation percentage of an amino acid in a therapeutic biomolecule. In one example, a method of predicting a glycation percentage of an amino acid in a biomolecule includes determining a first set of rates for a de-glycation...